WO2019039781A3 - Novel aeromonas salmonicida bacteriophage aer-sap-2 and use thereof in inhibiting proliferation of aeromonas salmonicida bacteria - Google Patents

Novel aeromonas salmonicida bacteriophage aer-sap-2 and use thereof in inhibiting proliferation of aeromonas salmonicida bacteria Download PDF

Info

Publication number
WO2019039781A3
WO2019039781A3 PCT/KR2018/009229 KR2018009229W WO2019039781A3 WO 2019039781 A3 WO2019039781 A3 WO 2019039781A3 KR 2018009229 W KR2018009229 W KR 2018009229W WO 2019039781 A3 WO2019039781 A3 WO 2019039781A3
Authority
WO
WIPO (PCT)
Prior art keywords
aeromonas salmonicida
sap
bacteria
novel
inhibiting proliferation
Prior art date
Application number
PCT/KR2018/009229
Other languages
French (fr)
Korean (ko)
Other versions
WO2019039781A2 (en
Inventor
윤성준
전수연
권안성
이호진
강상현
Original Assignee
주식회사 인트론바이오테크놀로지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 인트론바이오테크놀로지 filed Critical 주식회사 인트론바이오테크놀로지
Publication of WO2019039781A2 publication Critical patent/WO2019039781A2/en
Publication of WO2019039781A3 publication Critical patent/WO2019039781A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Animal Husbandry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to Myoviridae bacteriophage Aer-SAP-2(accession number KCTC 12909BP), isolated from nature, having an ability to kill Aeromonas salmonicida bacteria, and a genome represented by SEQ ID NO: 1, and a method for preventing or treating a disease caused by Aeromonas salmonicida bacteria, using a composition comprising the same bacteriophage as an effective ingredient.
PCT/KR2018/009229 2017-08-22 2018-08-10 Novel aeromonas salmonicida bacteriophage aer-sap-2 and use thereof in inhibiting proliferation of aeromonas salmonicida bacteria WO2019039781A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2017-0105842 2017-08-22
KR1020170105842A KR101875565B1 (en) 2017-08-22 2017-08-22 Novel Aeromonas salmonicida bacteriophage Aer-SAP-2 and its use for preventing proliferation of Aeromonas salmonicida

Publications (2)

Publication Number Publication Date
WO2019039781A2 WO2019039781A2 (en) 2019-02-28
WO2019039781A3 true WO2019039781A3 (en) 2019-06-27

Family

ID=62920837

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2018/009229 WO2019039781A2 (en) 2017-08-22 2018-08-10 Novel aeromonas salmonicida bacteriophage aer-sap-2 and use thereof in inhibiting proliferation of aeromonas salmonicida bacteria

Country Status (2)

Country Link
KR (1) KR101875565B1 (en)
WO (1) WO2019039781A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101875565B1 (en) * 2017-08-22 2018-07-06 주식회사 인트론바이오테크놀로지 Novel Aeromonas salmonicida bacteriophage Aer-SAP-2 and its use for preventing proliferation of Aeromonas salmonicida
CN110129279B (en) * 2019-04-24 2022-02-18 昆明理工大学 Enterococcus faecalis bacteriophage and separation, purification, enrichment and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101329639B1 (en) * 2012-06-04 2013-11-14 주식회사 씨티씨바이오 Novel bacteriophage asp-1 and its use for preventing proliferation of aeromonas salmonicida
KR101723827B1 (en) * 2015-10-28 2017-04-06 주식회사 인트론바이오테크놀로지 Novel Aeromonas salmonicida bacteriophage Aer-SAP-1 and its use for preventing proliferation of Aeromonas salmonicida
KR101875565B1 (en) * 2017-08-22 2018-07-06 주식회사 인트론바이오테크놀로지 Novel Aeromonas salmonicida bacteriophage Aer-SAP-2 and its use for preventing proliferation of Aeromonas salmonicida

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101329639B1 (en) * 2012-06-04 2013-11-14 주식회사 씨티씨바이오 Novel bacteriophage asp-1 and its use for preventing proliferation of aeromonas salmonicida
KR101723827B1 (en) * 2015-10-28 2017-04-06 주식회사 인트론바이오테크놀로지 Novel Aeromonas salmonicida bacteriophage Aer-SAP-1 and its use for preventing proliferation of Aeromonas salmonicida
KR101875565B1 (en) * 2017-08-22 2018-07-06 주식회사 인트론바이오테크놀로지 Novel Aeromonas salmonicida bacteriophage Aer-SAP-2 and its use for preventing proliferation of Aeromonas salmonicida

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE Archives of Virology 2015, "JUN, JIN WOO Genomic structure of the Aeromonas bacteriophage pAh6-C and its comparative genomic analysis" *
DATABASE Nucleotide 6 August 2014 (2014-08-06), "Aeromonas phage pAh6-C, complete genome", XP055619902, retrieved from NCBI Database accession no. KJ_858521.1 *

Also Published As

Publication number Publication date
KR101875565B1 (en) 2018-07-06
WO2019039781A2 (en) 2019-02-28

Similar Documents

Publication Publication Date Title
MX2017008561A (en) Novel clostridium perfringens bacteriophage clo-pep-1 and use thereof for inhibiting proliferation of clostridium perfringens.
MX2017008563A (en) Novel shigatoxin-producing f18 type e. coli bacteriophage esc-cop-1 and use thereof for inhibiting proliferation of shigatoxin-producing f18 type e. coli.
MX2017008562A (en) Novel enteroinvasive e. coli bacteriophage esc-cop-4 and use thereof for inhibiting proliferation of enteroinvasive e. coli.
MX2019009964A (en) Novel clostridium perfringens bacteriophage clo-pep-2 and use for inhibiting clostridium perfringens proliferation of same.
MX2020002727A (en) New use for treatment of clostridium difficile infections.
BR112018012044A2 (en) bacteriophage pas-mup-1 from innovative pasteurella multocida and use of it to inhibit the proliferation of pasteurella multocida
MX2016014807A (en) Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides.
WO2018155813A3 (en) Novel antibacterial protein efal-2 having bacteriolytic ability with respect to enterococcus faecium
MX2023000736A (en) Direct-fed microbials.
PH12019500838A1 (en) A feed composition for preventing or treating acute hepatopancreatic necrosis disease (ahpnd) or white spot syndrome (wss), comprising a bacillus subtilis strain as an active ingredient
PH12016502001A1 (en) Novel bacteriophage and composition comprising same
WO2019235782A8 (en) Novel streptococcus suis bacteriophage str-sup-2, and use thereof for inhibiting proliferation of streptococcus suis strains
WO2019039781A3 (en) Novel aeromonas salmonicida bacteriophage aer-sap-2 and use thereof in inhibiting proliferation of aeromonas salmonicida bacteria
MX2022016066A (en) Novel mek-inhibitor for the treatment of viral and bacterial infections.
MX2022001973A (en) Formulations for prevention or reduction of c. difficile infections.
WO2018236086A3 (en) Novel aeromonas hydrophila bacteriophage aer-hyp-2 and use thereof in preventing proliferation of aeromonas hydrophila
WO2018117462A3 (en) Novel vibrio parahaemolyticus bacteriophage vib-pap-4 and use thereof in inhibiting proliferation of vibrio parahaemoliticus bacteria
MX2020008677A (en) Novel salmonella heidelberg bacteriophage sal-hep-1 and use thereof for inhibiting growth of salmonella heidelberg bacteria.
WO2011155727A3 (en) Method for preventing and treating infection caused by salmonella choleraesuis or salmonella dublin
WO2019235783A8 (en) Novel streptococcus suis bacteriophage str-sup-3, and use thereof for inhibiting proliferation of streptococcus suis strains
WO2018101595A3 (en) Escherichia coli bacteriophage esc-cop-9 and use for inhibiting proliferation of pathogenic escherichia coli thereof
MX2020013857A (en) Non-viable bifidobacterium bifidum bacteria and uses thereof.
MX2021012604A (en) Novel mek-inhibitor for the treatment of viral and bacterial infections.
MX2022003871A (en) Immunogenic compositions.
MX2021000949A (en) New attenuated virus strain and use thereof as a vaccine.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18847983

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18847983

Country of ref document: EP

Kind code of ref document: A2